返回 Agendas
Session Chair(s)
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Current Issues in Antibacterial Drug Development for Drug-Resistant Pathogens
Seiji Hori, MD, PhD
Jikei University School of Medicine, Japan
Professor, Department of Infections Diseases and Infection Control
Call For Action Revolutionizing anti-bacterial drugs’ R&D ecosystem
Hiromichi Shirasawa, MD
MSD K.K., Japan
Vice President and Executive Officer, Head of Japan Development
Evolution of the regulatory framework in the US and EU to support streamlined development of new antibiotics
John Rex, MD
AstraZeneca, United States
Senior VP and Head of Infection, Global Medicines Development
Wataru Asakura, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office Director, Office of New Drug IV